Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats

PPAR Research

Volumn , Issue , 2012, Pages

  Gao, Dengfeng ^a   Ning, Ning ^a   Hao, Guanghua ^a   Niu, Xiaolin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDRALAZINE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; MALE; MASSON TRICHROME STAINING; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; STAINING; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; TREATMENT RESPONSE; VASCULAR FIBROSIS; WESTERN BLOTTING; WISTAR KYOTO RAT;

EID: 84861081373     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/856426     Document Type: Article

References (32)

1. Briones A. M., Arribas S. M., Salaices M., Role of extracellular matrix in vascular remodeling of hypertension Current Opinion in Nephrology and Hypertension 2010 19 2 187 194
2. Ruiz-Ortega M., Rodrguez-Vita J., Sanchez-Lopez E., Carvajal G., Egido J., TGF- signaling in vascular fibrosis Cardiovascular Research 2007 74 2 196 206
3. Blom I. E., Goldschmeding R., Leask A., Gene regulation of connective tissue growth factor: (Pubitemid 35248272)
4. Cicha I., Yilmaz A., Klein M., Raithel D., Brigstock D. R., Daniel W. G., Goppelt-Struebe M., Garlichs C. D., Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 5 1008 1013 (Pubitemid 40627847)
5. Finckenberg P., Lassila M., Inkinen K., Pere A. K., Krogerus L., Lindgren L., Mervaala E., Vapaatalo H., Nurminen M. L., Ahonen J., Cyclosporine induces myocardial connective tissue growth factor in spontaneously hypertensive rats on high-sodium diet Transplantation 2001 71 7 951 958 (Pubitemid 32417358)
6. Fan W. H., Pech M., Karnovsky M. J., Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro European Journal of Cell Biology 2000 79 12 915 923 (Pubitemid 32000725)
7. Hishikawa K., Oemar B. S., Tanner F. C., Nakaki T., Fujii T., Lscher T. F., Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells Circulation 1999 100 20 2108 2112 (Pubitemid 29532063)
8. Ruperez M., Lorenzo O., Blanco-Colio L. M., Esteban V., Egido J., Ruiz-Ortega M., Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis Circulation 2003 108 12 1499 1505 (Pubitemid 37176458)
9. Cheatham W. W., Peroxisome proliferator-activated receptor translational research and clinical experience American Journal of Clinical Nutrition 2010 91 1 262S 266S
10. Nakamura T., Yamamoto E., Kataoka K., Yamashita T., Tokutomi Y., Dong Y. F., Matsuba S., Ogawa H., Kim-Mitsuyama S., Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan Hypertension 2008 51 2 296 301 (Pubitemid 351159942)
11. Schiffrin E. L., Peroxisome proliferator-activated receptors and cardiovascular remodeling American Journal of Physiology 2005 288 3 H1037 H1043
12. Molavi B., Chen J., Mehta J. L., Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK American Journal of Physiology 2006 291 2 H687 H693
13. Iglarz M., Touyz R. M., Amiri F., Lavoie M.-F., Diep Q. N., Schiffrin E. L., Effect of peroxisome proliferator-activated receptor- and- activators on vascular remodeling in endothelin-dependent hypertension Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 1 45 51 (Pubitemid 36091624)
14. Diep Q. N., Mabrouk M. E., Cohn J. S., Endemann D., Amiri F., Virdis A., Neves M. F., Schiffrin E. L., Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor- Circulation 2002 105 19 2296 2302 (Pubitemid 34535341)
15. Diep Q. N., Amiri F., Benkirane K., Paradis P., Schiffrin E. L., Long-term effects of the PPAR activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats Canadian Journal of Physiology and Pharmacology 2004 82 11 976 985 (Pubitemid 40223210)
16. Gao D. F., Niu X. L., Hao G. H., Peng N., Wei J., Ning N., Wang N. P., Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cellsrole of PPAR- in vascular fibrosis Biochemical Pharmacology 2007 73 2 185 197 (Pubitemid 44855720)
17. Chang S., Chen W., Yang J., Another formula for calculating the gene change rate in real-time RT-PCR Molecular Biology Reports 2009 36 8 2165 2168
18. Ballester M., Castell A., Ibez E., Snchez A., Folch J. M., Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals BioTechniques 2004 37 4 610 613 (Pubitemid 39391178)
19. Tun J., Ruiz-Ortega M., Egido J., Regulation of matrix proteins and impact on vascular structure Current Hypertension Reports 2000 2 1 106 113
20. Susic D., Varagic J., Ahn J., Frohlich E. D., Collagen cross-link breakers: a beginning of a new Era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension Current Drug Targets 2004 4 1 97 101 (Pubitemid 38404718)
21. Horio T., Suzuki M., Suzuki K., Takamisawa I., Hiuge A., Kamide K., Takiuchi S., Iwashima Y., Kihara S., Funahashi T., Yoshimasa Y., Kawano Y., Pioglitazone improves left ventricular diastolic function in patients with essential hypertension American Journal of Hypertension 2005 18 7 949 957 (Pubitemid 41040266)
22. Majithiya J. B., Parmar A. N., Trivedi C. J., Balaraman R., Effect of pioglitazone on L-NAME induced hypertension in diabetic rats Vascular Pharmacology 2005 43 4 260 266 (Pubitemid 41586213)
23. Fullert S., Schneider F., Haak E., Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study The Journal of Clinical Endocrinology Metabolism 2002 87 12 5503 5506 (Pubitemid 36034352)
24. Kaufman L. N., Peterson M. M., DeGrange L. M., Pioglitazone attenuates diet-induced hypertension in rats Metabolism 1995 44 9 1105 1109 (Pubitemid 26084027)
25. Ihn H., Pathogenesis of fibrosis: role of TGF-beta and CTGF Current Opinion in Rheumatology 2002 14 6 681 685 (Pubitemid 35191556)
26. Leask A., Holmes A., Abraham D. J., Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis Current Rheumatology Reports 2002 4 2 136 142
27. Shinzato T., Ohya Y., Nakamoto M., Ishida A., Takishita S., Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats Hypertension Research 2007 30 9 863 873 (Pubitemid 47578249)
28. Rodrguez-Vita J., Snchez-Lpez E., Esteban V., Rupérez M., Egido J., Ruiz-Ortega M., Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor- -independent mechanism Circulation 2005 111 19 2509 2517 (Pubitemid 40696140)
29. Dez R. R., Rodrigues-Dez R., Lavoz C., Rayego-Mateos S., Civantos E., Rodrguez-Vita J., Mezzano S., Ortiz A., Egido J., Ruiz-Ortega M., Statins inhibit angiotensin II/smad pathway and related vascular fibrosis, by a TGF- -independent process Plos ONE 2010 5 11
30. Zafiriou S., Stanners S. R., Saad S., Polhill T. S., Poronnik P., Pollock C. A., Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts Journal of the American Society of Nephrology 2005 16 3 638 645 (Pubitemid 41725100)
31. Hao G. H., Niu X. L., Gao D. F., Wei J., Wang N. P., Agonists at PPAR- suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts British Journal of Pharmacology 2008 153 7 1409 1419 (Pubitemid 351481520)
32. Kim J. S., Kim I. K., Lee S. Y., The anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway Cell Biology International 2012 36 3 305 310